Download the Article
Flow Cytometry: Its Role in Clinical Trial Biomarkers
Flow Cytometry: Its Role in Clinical Trial Biomarkers
Successfully Executing Biomarker Strategies
Medpace has an experienced flow cytometry team overseen by PhD-level scientists with over 50 years of team cumulative experience designing, analyzing, and interpreting multicolor flow cytometry assays. In addition to in-house validated, ready-to-go panels (e.g., TBNK, T-Cell, B Cell, NK Cell, Dendritic Cell, Monocyte, Stem/Progenitor Panel, and PNH), we also offer study-specific fully customized panels with capacity for more than 20 colors.
Whether a study requires the development of a custom panel or the transfer of a method, we have the experience to quickly validate and implement flow cytometry testing. Medpace has harmonized global flow cytometry capabilities at the US, Belgium, and Singapore laboratories.
Click image to access full article.
Global Labs – Fully Integrated for Efficiency
Since most clinical trial requires laboratory support, having wholly-owned entities with a broad range of capabilities and comprehensive test menus provides built-in efficiencies and collaboration. In concert with the Medpace CRO or working on standalone projects, experts from our central laboratories and bioanalytical laboratory can help plan and execute your testing needs.
